Iván Hernández Dalas: First patient enrolls in clinical trial for Wandercraft Atalante X exoskeleton
The Atalante X self-supporting exoskeleton is being tested for clinical use. Source: Wandercraft Robotics and wearable technologies show promise in helping patients in rehabilitation. The first patient has enrolled in a new clinical trial at Brigham and Women’s Hospital for Atalante X, a robotic exoskeleton from Wandercraft. “This pilot study is designed to answer an important, practical question: Can Atalante X, a self-balancing exoskeleton, be used safely and effectively in a thoracic surgical ICU [intensive care unit]?” said Matthieu Masselin, co-founder and CEO of Wandercraft. Thoracic surgery patients are often unable to stand for even a minute without the assistance of two or more healthcare providers, according to ICU clinicians. The first days after surgery are often a difficult period for mobilizing a patient, but even a few minutes of upright posture can benefit cardiorespiratory function, vital sign stability, muscle preservation, and psychological well-being, Wandercr...